Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study
Journal of Clinical Oncology - United States
doi 10.1200/jco.18.00454
Full Text
Open PDFAbstract
Available in full text
Date
November 20, 2018
Authors
Publisher
American Society of Clinical Oncology (ASCO)